XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Net revenues (Tables)
 9 Months Ended
Sep. 28, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Major Customers by Reporting Segments
The following table disaggregates revenue by global product category for the three and nine months ended September 28, 2025 and September 29, 2024.
Three Months EndedNine Months Ended
September 28, 2025September 29, 2024September 28, 2025September 29, 2024
Vascular access$191,021 $180,896 $558,919 $543,355 
Interventional
266,412 149,865 573,990 425,687 
Anesthesia101,449 101,154 284,429 299,997 
Surgical122,879 111,746 342,706 328,574 
Interventional urology71,770 83,395 219,125 246,241 
OEM80,412 82,558 222,971 259,080 
Other (1)
79,078 54,761 192,439 148,981 
Net revenues (2)
$913,021 $764,375 $2,394,579 $2,251,915 
(1)    Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products) as well as adjustments in our reserves related to the Italian payback measure pertaining to prior years. Refer to Note 13 for additional information.
(2)    The product categories listed above are presented on a global basis, as each of our reportable segments are defined based on the geographic location of its operations